CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE
Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus (DM 2) in current clinical practice.Material and methods. A total of 200 patients with DM 2, who consented to take part in the questionnaire, were examined. Questionnaire, clinical and laboratory exami...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/655 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839641462691594240 |
|---|---|
| author | I. E. Sapozhnikova E. I. Tarlovskaya E. N. Anufrieva |
| author_facet | I. E. Sapozhnikova E. I. Tarlovskaya E. N. Anufrieva |
| author_sort | I. E. Sapozhnikova |
| collection | DOAJ |
| description | Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus (DM 2) in current clinical practice.Material and methods. A total of 200 patients with DM 2, who consented to take part in the questionnaire, were examined. Questionnaire, clinical and laboratory examinations were conducted.Results. There was a low frequency of CVD recognized and included into clinical diagnosis – angina, history of myocardial infarction and stroke. In majority of the patients decompensated carbohydrate metabolism was observed. This was due to lack of knowledge, inadequate or absent glucose self-monitoring, low frequency of combined glucoselowering therapy. Target level of blood pressure (BP) was registered in 16% of hypertensive patients only. Basic reasons of this were: frequently prescribed mono-therapy, irrational combinations, inadequate dosage and frequent omissions of antihypertensive drugs intake and not appropriate BP self-monitoring. Low frequency of statins therapy and non-targeted cholesterol levels were also revealed in examined patients.Conclusion. Improvement of diagnostic tactics in patients with DM 2 is necessary as well as therapy correction taking into account these patients co-morbidity. |
| format | Article |
| id | doaj-art-d00af4da88304b718a8fbf39c0c11f01 |
| institution | Matheson Library |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-d00af4da88304b718a8fbf39c0c11f012025-07-03T07:28:26ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-015381310.20996/1819-6446-2009-5-3-8-13654CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICEI. E. Sapozhnikova0E. I. Tarlovskaya1E. N. Anufrieva2Kirov State Medical AcademyKirov State Medical AcademyKirov State Medical AcademyAim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus (DM 2) in current clinical practice.Material and methods. A total of 200 patients with DM 2, who consented to take part in the questionnaire, were examined. Questionnaire, clinical and laboratory examinations were conducted.Results. There was a low frequency of CVD recognized and included into clinical diagnosis – angina, history of myocardial infarction and stroke. In majority of the patients decompensated carbohydrate metabolism was observed. This was due to lack of knowledge, inadequate or absent glucose self-monitoring, low frequency of combined glucoselowering therapy. Target level of blood pressure (BP) was registered in 16% of hypertensive patients only. Basic reasons of this were: frequently prescribed mono-therapy, irrational combinations, inadequate dosage and frequent omissions of antihypertensive drugs intake and not appropriate BP self-monitoring. Low frequency of statins therapy and non-targeted cholesterol levels were also revealed in examined patients.Conclusion. Improvement of diagnostic tactics in patients with DM 2 is necessary as well as therapy correction taking into account these patients co-morbidity.https://www.rpcardio.online/jour/article/view/655type 2 diabetes mellitusessential hypertensionantihypertensive therapystatins |
| spellingShingle | I. E. Sapozhnikova E. I. Tarlovskaya E. N. Anufrieva CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE Рациональная фармакотерапия в кардиологии type 2 diabetes mellitus essential hypertension antihypertensive therapy statins |
| title | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE |
| title_full | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE |
| title_fullStr | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE |
| title_full_unstemmed | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE |
| title_short | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE |
| title_sort | cardiovascular diseases treatment in patients with type 2 diabetes mellitus in current clinical practice |
| topic | type 2 diabetes mellitus essential hypertension antihypertensive therapy statins |
| url | https://www.rpcardio.online/jour/article/view/655 |
| work_keys_str_mv | AT iesapozhnikova cardiovasculardiseasestreatmentinpatientswithtype2diabetesmellitusincurrentclinicalpractice AT eitarlovskaya cardiovasculardiseasestreatmentinpatientswithtype2diabetesmellitusincurrentclinicalpractice AT enanufrieva cardiovasculardiseasestreatmentinpatientswithtype2diabetesmellitusincurrentclinicalpractice |